Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phosphatidylinositol 3-kinase beta (PI3Kβ) is a Class IA PI3K, a lipid kinase that phosphorylates phosphoinositides. It is a heterodimer composed of a catalytic subunit (p110β) and a regulatory subunit (p85, p55, or p50). PI3Kβ integrates signals from receptor tyrosine kinases (RTKs), G protein-coupled receptors (GPCRs), and small GTPases. It plays critical roles in various physiological processes, including spermatogenesis, macrophage function, osteoclast development, neutrophil function, and platelet activation. Dysregulation of PI3Kβ is linked to cancer, thrombosis, male infertility, and Fragile X syndrome. Selective inhibitors are under development as potential therapeutics.
Selective inhibition of PI3Kβ
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphatidylinositol 3-Kinase Beta (PI3Kβ).